FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Teresa Petrucci

Research Profile

Disorders

Multiple Myeloma

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Cell Cycle

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Tommaso Za; Alessandro Andriani; Luciana Annino; Silvia Betti; Velia Bongarzoni; Elisabetta Calabrese; Tommaso Caravita; Angela Ciminello; Giuseppe Cimino; Valerio De Stefano; Stefano Felici; Fabiana Gentilini; Giuseppe Leone; Anna Levi; Maria Teresa Petrucci; Francesco Pisani; Angela Rago; Elena Rossi; F Torelli; Nicoletta Villivà
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
Angela Rago; Agostina Siniscalchi; Tommaso Za; Velia Bongarzoni; Tommaso Caravita; Giuseppe Cimino; Luca De Rosa; Valerio De Stefano; Stefano Felici; Luca Franceschini; Sara Grammatico; Giacinto La Verde; Anna Levi; Sergio Mecarocci; Anna Lisa Paviglianiti; Maria Teresa Petrucci; Anna Lina Piccioni; Francesco Pisani
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
Claudio Cartoni; Luca Cupelli; Gianna Maria D'Elia; Fabio Efficace; Vincenzo Federico; Sara Grammatico; Pasquale Niscola; Laura Scaramucci; Andrea Tendas; Andrea Truini; Gregorio Antonio Brunetti; Maria Teresa Petrucci
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Teresa Petrucci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tommaso Za; Alessandro Andriani; Luciana Annino; Silvia Betti; Velia Bongarzoni; Elisabetta Calabrese; Tommaso Caravita; Angela Ciminello; Giuseppe Cimino; Valerio De Stefano; Stefano Felici; Fabiana Gentilini; Giuseppe Leone; Anna Levi; Maria Teresa Petrucci; Francesco Pisani; Angela Rago; Elena Rossi; F Torelli; Nicoletta Villivà
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
British journal of haematology 2013;160(5):673-9.
2012: Angela Rago; Agostina Siniscalchi; Tommaso Za; Velia Bongarzoni; Tommaso Caravita; Giuseppe Cimino; Luca De Rosa; Valerio De Stefano; Stefano Felici; Luca Franceschini; Sara Grammatico; Giacinto La Verde; Anna Levi; Sergio Mecarocci; Anna Lisa Paviglianiti; Maria Teresa Petrucci; Anna Lina Piccioni; Francesco Pisani
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
Cancer 2012;118(22):5544-9.
2012: Claudio Cartoni; Luca Cupelli; Gianna Maria D'Elia; Fabio Efficace; Vincenzo Federico; Sara Grammatico; Pasquale Niscola; Laura Scaramucci; Andrea Tendas; Andrea Truini; Gregorio Antonio Brunetti; Maria Teresa Petrucci
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(10):2621-6.
2012: Maria Rosaria Ricciardi; Maria Cristina Scerpa; Linda S Steelman; Agostino Tafuri; Simona Tavolaro; Twee Tsao; Maria Teresa Petrucci; Stephen L Abrams; Michael Andreeff; Paola Bergamo; Sabina Chiaretti; Ludovica Ciuffreda; Francesco Cognetti; Donatella Del Bufalo; Robin Foà; Marina Konopleva; Antonio Marchetti; Maria Grazia Mascolo; James A McCubrey; Michele Milella
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies.
Journal of molecular medicine (Berlin, Germany) 2012;90(10):1133-44.
2012: Michele Cavo; Claudia Crippa; Valerio De Stefano; Daniele Derudas; Maria Laura Dessanti; Daniela Donnarumma; Antonietta Falcone; Felicetto Ferrara; Anna Furlan; Mariella Grasso; Magda Marcatti; Luciano Masini; Pellegrino Musto; Andrea Nozza; Chiara Nozzoli; Antonio Palumbo; Lucia Pantani; Francesca Patriarca; Giulia Perrone; Maria Teresa Petrucci; Annalisa Pezzi; Elena Zamagni; Renato Zambello; Stelvio Ballanti; Anna Baraldi; Mario Boccadoro; Annamaria Brioli; Catello Califano; Vincenzo Callea; Angelo Michele Carella
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Blood 2012;120(1):9-19.
2012: Antonio Palumbo; Maria Teresa Petrucci; Torben Plesner; Joergen Radke; Ivan Spicka; Katja Weisel; Wiesław Wiktor-Jędrzejczak; Zhinuan Yu; Mamia Zodelava; Meral Beksac; Dina Ben Yehuda; Joan Bladé; Nicola Cascavilla; John Catalano; Michele Cavo; Alessandro Corso; Michel Delforge; Meletios A Dimopoulos; Heinz Gisslinger; Roman Hajek; Lindsay Herbein; Genadi Iosava; Christian Jacques; Janusz Kloczko; Martin Kropff; Christian Langer; Jay Mei
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
The New England journal of medicine 2012;366(19):1759-69.
2012: Vincenzo Federico; Anna Levi; Giuseppina Loglisci; Giovanna Mansueto; Caterina Mercanti; Pellegrino Musto; Maria Teresa Petrucci; Massimo Breccia; Claudio Cartoni; Giuliana Alimena
Efficacy of bortezomib in systemic extramedullary localizations of multiple myeloma.
Clinical advances in hematology & oncology : H&O 2012;10(4):266-8.
2012: A Andriani; Giuseppe Avvisati; Velia Bongarzoni; Tommaso Caravita; U Coppetelli; M De Muro; A Levi; Marco Montanaro; Maria Teresa Petrucci; F Pisani; A Siniscalchi; Nicoletta Villivà; A Zullo; A Agrillo; D Gaglioti
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study.
Blood cancer journal 2012;2(3):e62.
2012: Alessandra Larocca; Arnon Nagler; Francesca Patriarca; Jacopo Peccatori; Maria Teresa Petrucci; Sara Pezzatti; Agostina Siniscalchi; Anfisa Stanevsky; Dina Ben Yehuda; Eloise Beggiato; Mario Boccadoro; Sara Bringhen; Anna Maria Cafro; Angelo Michele Carella; Lucio Catalano; Maide Cavalli; Federica Cavallo; Michele Cavo; Paolo Corradini; Claudia Crippa; Francesco Di Raimondo; Tommaso Caravita Di Toritto; Andrea Evangelista; Anna Falanga; Antonio Palumbo
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Blood 2012;119(4):933-9; quiz 1093.
2012: Francesco Pisani; Tommaso Za; Luciana Annino; Velia Bongarzoni; Valerio De Stefano; Fabiana Gentilini; Diana Giannarelli; Giacinto La Verde; Anna Levi; Marco Montanaro; Alessandro Moscetti; Maria Teresa Petrucci; Maria Concetta Petti
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy.
Journal of experimental & clinical cancer research : CR 2012;31():17.
2011: Fortunato Morabito; Caterina Musolino; Pellegrino Musto; Chiara Nozzoli; Massimo Offidani; Francesca Patriarca; Maria Teresa Petrucci; Roberto Ria; Davide Rossi; Iolanda Vincelli; Luca Baldini; Giulia Benevolo; Mario Boccadoro; Sara Bringhen; Nicola Cascavilla; Michele Cavo; Francesco Di Raimondo; Massimo Gentile; Mariella Grasso; Tommasina Guglielmelli; Ignazio Majolino; Marasca Roberto; Carla Mazzone; Vittorio Montefusco; Antonio Palumbo
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
Blood 2011;118(22):5759-66.
2011: F Cavallo; C Crippa; A M Liberati; B Lupo; Giuseppe Milone; Vittorio Montefusco; Pellegrino Musto; A Nagler; Paola Omedè; D Ben-Yehuda; Mario Boccadoro; Sara Bringhen; Anna Maria Cafro; E Calabrese; Tommaso Caravita; Angelo Michele Carella; N Cascavilla; L Catalano; Roberto Passera; Francesca Patriarca; Jacopo Peccatori; Maria Teresa Petrucci; F Rossini; Antonio Palumbo
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy.
Leukemia 2011;25(10):1627-31.
2011: Tommasina Guglielmelli; Sara Bringhen; S Rrodhe; Francesca Gay; Federica Cavallo; Alfredo Berruti; Vittorio Montefusco; E Piro; G Benevolo; Maria Teresa Petrucci; Tommaso Caravita; M Offidani; Paolo Corradini; Mario Boccadoro; Giuseppe Saglio; Antonio Palumbo
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients.
European journal of cancer (Oxford, England : 1990) 2011;47(6):814-8.
2011: Francesca Gay; Alessandra Larocca; Pierre Wijermans; Federica Cavallo; Davide Rossi; Ron Schaafsma; Mariella Genuardi; Alessandra Romano; Anna Marina Liberati; Agostina Siniscalchi; Maria Teresa Petrucci; Chiara Nozzoli; Francesca Patriarca; Massimo Offidani; Roberto Ria; Paola Omedè; Benedetto Bruno; Roberto Passera; Pellegrino Musto; Mario Boccadoro; Pieter Sonneveld; Antonio Palumbo
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients.
Blood 2011;117(11):3025-31.
2011: Tommasina Guglielmelli; Maria Teresa Petrucci; Giuseppe Saglio; Antonio Palumbo
Thalidomide after lenalidomide: a possible treatment regimen in relapse refractory multiple myeloma patients.
British journal of haematology 2011;152(1):108-10.
2010: Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia Pantani; Monica Galli; Francesco Di Raimondo; Claudia Crippa; Elena Zamagni; Antonio Palumbo; Massimo Offidani; Paolo Corradini; Franco Narni; Antonio Spadano; Norbert Pescosta; Giorgio Lambertenghi Deliliers; Antonio Ledda; Claudia Cellini; Tommaso Caravita; Patrizia Tosi; Michele Baccarani
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
Lancet 2010;376(9758):2075-85.
2010: Antonio Palumbo; Sara Bringhen; Davide Rossi; Maide Cavalli; Alessandra Larocca; Roberto Ria; Massimo Offidani; Francesca Patriarca; Chiara Nozzoli; Tommasina Guglielmelli; Giulia Benevolo; Vincenzo Callea; Luca Baldini; Fortunato Morabito; Mariella Grasso; Giovanna Leonardi; Manuela Rizzo; Antonietta Pia Falcone; Daniela Gottardi; Vittorio Montefusco; Pellegrino Musto; Maria Teresa Petrucci; Giovannino Ciccone; Mario Boccadoro
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(34):5101-9.
2010: Antonio Palumbo; A Larocca; Patrizia Falco; G Sanpaolo; Antonietta Falcone; V Federico; L Canepa; monica crugnola; M Genuardi; V Magarotto; Maria Teresa Petrucci; Mario Boccadoro
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma.
Leukemia 2010;24(5):1037-42.
2010: Antonio Palumbo; Sara Bringhen; Benedetto Bruno; Antonietta Pia Falcone; Anna Marina Liberati; Mariella Grasso; Roberto Ria; Francesco Pisani; Clotilde Cangialosi; Tommaso Caravita; Anna Levi; Giovanna Meloni; Andrea Nozza; Patrizia Pregno; Attilio Gabbas; Vincenzo Callea; Manuela Rizzo; Luciana Annino; Valerio De Stefano; Pellegrino Musto; Ileana Baldi; Federica Cavallo; Maria Teresa Petrucci; Massimo Massaia; Mario Boccadoro
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.
Blood 2010;115(10):1873-9.
2010: Antonio Palumbo; Francesca Gay; Patrizia Falco; Claudia Crippa; Vittorio Montefusco; Francesca Patriarca; Fausto Rossini; Simona Caltagirone; Giulia Benevolo; Norbert Pescosta; Tommasina Guglielmelli; Sara Bringhen; Massimo Offidani; Nicola Giuliani; Maria Teresa Petrucci; Pellegrino Musto; Anna Marina Liberati; Giuseppe Rossi; Paolo Corradini; Mario Boccadoro
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):800-7.
2009: Pellegrino Musto; Fiorella D'Auria; Giuseppe Pietrantuono; Luca Baldini; Sara Bringhen; Tommaso Caravita; Francesco Di Raimondo; Fortunato Morabito; Massimo Offidani; Maria Teresa Petrucci; Patrizia Tosi; Francesca Gay; Michele Cavo; Mario Boccadoro; Antonio Palumbo
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective.
Current drug targets 2009;10(10):906-22.
2009: Antonio Palumbo; Patrizia Falco; Antonietta Falcone; Giulia Benevolo; Letizia Canepa; Francesca Gay; Alessandra Larocca; Valeria Magarotto; Alessandro Gozzetti; Annalisa Luraschi; Fortunato Morabito; Andrea Nozza; Robert D Knight; Jerome B Zeldis; Mario Boccadoro; Maria Teresa Petrucci
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.
Clinical lymphoma & myeloma 2009;9(2):145-50.
2009: Francesca Patriarca; Maria Teresa Petrucci; Sara Bringhen; Luca Baldini; Tommaso Caravita; Paolo Corradini; Alessandro Corso; Francesco Di Raimondo; Antonietta Falcone; Felicetto Ferrara; Fortunato Morabito; Pellegrino Musto; Massimo Offidani; Mario Petrini; Rita Rizzi; Gianpietro Semenzato; Patrizia Tosi; Angelo Vacca; Michele Cavo; Mario Boccadoro; Antonio Palumbo
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts.
European journal of haematology 2009;82(2):93-105.
2008: Pellegrino Musto; Maria Teresa Petrucci; Sara Bringhen; Tommasina Guglielmelli; Tommaso Caravita; Velia Bongarzoni; Alessandro Andriani; Giovanni D'Arena; Enrico Balleari; Giuseppe Pietrantuono; Mario Boccadoro; Antonio Palumbo
A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma.
Cancer 2008;113(7):1588-95.
2007: Antonio Palumbo; Patrizia Falco; Paolo Corradini; Antonietta Falcone; Francesco Di Raimondo; Nicola Giuliani; Claudia Crippa; Giovannino Ciccone; Paola Omedè; Maria Teresa Ambrosini; Francesca Gay; Sara Bringhen; Pellegrino Musto; Robin Foà; Robert Knight; Jerome B Zeldis; Mario Boccadoro; Maria Teresa Petrucci
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4459-65.
2007: Maria Teresa Petrucci; Cristiano Gallucci; Alessandro Agrillo; Maria Cristina Mustazza; Robin Foà
Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients.
Haematologica 2007;92(9):1289-90.
2007: Chiara Gregorj; Maria R Ricciardi; Maria Teresa Petrucci; Maria C Scerpa; Fabiana De Cave; Paola Fazi; Marco Vignetti; Antonella Vitale; Marco Mancini; Giuseppe Cimino; Salvatore Palmieri; Francesco Di Raimondo; Giorgina Specchia; Francesco Fabbiano; Nicola Cantore; Federico Mosna; Andrea Camera; Mario Luppi; Luciana Annino; Eustachio Miraglia; Giuseppe Fioritoni; Francesca Ronco; Giovanna Meloni; Franco Mandelli; Michael Andreeff; Michele Milella; Robin Foà; Agostino Tafuri
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.
Blood 2007;109(12):5473-6.
2007: Luisa Giaccone; Roberto Sorasio; Francesca Patriarca; Daniele Mattei; Vittorio Montefusco; Jacopo Peccatori; Fabrizio Carnevale-Schianca; Maria Teresa Petrucci; Giuseppe Milone; Stefano Guidi; Marcello Rotta; Renato Fanin; Paolo Corradini; Mario Boccadoro; Benedetto Bruno
Bortezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):497-9.
2007: Michele Milella; Marina Konopleva; Cristina M Precupanu; Yoko Tabe; Maria R Ricciardi; Chiara Gregorj; Steven J Collins; Bing Z Carter; Carmen D'Angelo; Maria Teresa Petrucci; Robin Foà; Francesco Cognetti; Agostino Tafuri; Michael Andreeff
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis.
Blood 2007;109(5):2121-9.
2007: Maria Teresa Petrucci; Vincenza Martini; Anna Levi; Cristiano Gallucci; Giovanna Palumbo; Patrizia Del Bianco; Concetta Torromeo; Robin Foà
Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center.
Leukemia & lymphoma 2007;48(1):180-2.
2006: Alessandro Agrillo; Maria Teresa Petrucci; Massimiliano Tedaldi; Maria Cristina Mustazza; Simone Maria Faustino Marino; Cristiano Gallucci; Giorgio Iannetti
New therapeutic protocol in the treatment of avascular necrosis of the jaws.
The Journal of craniofacial surgery 2006;17(6):1080-3.
2006: Jessica Pepe; Maria Teresa Petrucci; Italo Nofroni; Valeria Fassino; Daniele Diacinti; Elisabetta Romagnoli; Salvatore Minisola
Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance.
British journal of haematology 2006;134(5):485-90.
2006: Ombretta Annibali; Maria Teresa Petrucci; Patrizia Del Bianco; Cristiano Gallucci; Anna Levi; Robin Foà; Giuseppe Avvisati
IgM multiple myeloma: report of four cases and review of the literature.
Leukemia & lymphoma 2006;47(8):1565-9.
2006: Benedetto Bruno; Francesca Patriarca; Roberto Sorasio; Daniele Mattei; Vittorio Montefusco; Jacopo Peccatori; Francesca Bonifazi; Maria Teresa Petrucci; Giuseppe Milone; Stefano Guidi; Luisa Giaccone; Marcello Rotta; Renato Fanin; Mario Boccadoro; Paolo Corradini
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation.
Haematologica 2006;91(6):837-9.
2006: Antonio Palumbo; Sara Bringhen; Tommaso Caravita; Emanuela Merla; Vincenzo Capparella; Vincenzo Callea; Clotilde Cangialosi; Mariella Grasso; Fausto Rossini; Monica Galli; Lucio Catalano; Elena Zamagni; Maria Teresa Petrucci; Valerio De Stefano; Manuela Ceccarelli; Maria Teresa Ambrosini; Ilaria Avonto; Patrizia Falco; Giovannino Ciccone; Anna Marina Liberati; Pellegrino Musto; Mario Boccadoro
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
Lancet 2006;367(9513):825-31.
2006: Saveria Capria; Maria Teresa Petrucci; Alessandro Pulsoni; Michela Ribersani; Erminia Baldacci; Maria Stefania De Propris; Giovanna Meloni
High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: comparison with a historical control.
Acta haematologica 2006;115(1-2):9-14.
2005: Antonio Palumbo; Patrizia Falco; Maria Teresa Ambrosini; Maria Teresa Petrucci; Pellegrino Musto; Tommaso Caravita; Patrizia Pregno; Alessandra Bertola; Federica Cavallo; Giovannino Ciccone; Mario Boccadoro
Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant.
European journal of haematology 2005;75(5):391-5.
2005: Antonio Palumbo; Maria Teresa Petrucci; Vito Michele Lauta; Pellegrino Musto; Tommaso Caravita; Anna Barbui; Martina Nunzi; Mario Boccadoro
Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional study.
Haematologica 2005;90(6):858-60.
2005: Lidia De Felice; Caterina Tatarelli; Maria Grazia Mascolo; Chiara Gregorj; Francesca Agostini; Roberto Fiorini; Vania Gelmetti; Simona Pascale; Fabrizio Padula; Maria Teresa Petrucci; William Arcese; Clara Nervi
Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.
Cancer research 2005;65(4):1505-13.
2005: Ombretta Annibali; Maria Teresa Petrucci; Vincenza Martini; Maria Cristina Tirindelli; Anna Levi; Carolina Fossati; Patrizia Del Bianco; Franco Mandelli; Robin Foa; Giuseppe Avvisati
Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysis.
Cancer 2005;103(3):582-7.
2005: Michele Milella; C M Precupanu; Chiara Gregorj; Maria R Ricciardi; Maria Teresa Petrucci; Steven M Kornblau; Agostino Tafuri; Michael Andreeff
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects.
Current pharmaceutical design 2005;11(21):2779-95.
2004: Antonio Palumbo; Sara Bringhen; Maria Teresa Petrucci; Pellegrino Musto; Fausto Rossini; Martina Nunzi; Vito Michele Lauta; Cesare Bergonzi; Anna Barbui; Tommaso Caravita; Antonio Capaldi; Patrizia Pregno; Tommasina Guglielmelli; Mariella Grasso; Vincenzo Callea; Alessandra Bertola; Federica Cavallo; Patrizia Falco; Cecilia Rus; Massimo Massaia; Franco Mandelli; Angelo Michele Carella; Enrico Pogliani; Anna Marina Liberati; Franco Dammacco; Giovannino Ciccone; Mario Boccadoro
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.
Blood 2004;104(10):3052-7.
2004: Maria R Ricciardi; Maria Teresa Petrucci; Chiara Gregorj; Vincenza Martini; Anna Levi; Maria Rosaria De Cuia; Roberto Latagliata; Maria Concetta Petti; Franco Mandelli; Robin Foà; Agostino Tafuri
Apoptosis susceptibility and cell-cycle distribution in cells from myelodysplastic syndrome patients: modulatory in-vitro effects of G-CSF and interferon-alpha.
Leukemia & lymphoma 2004;45(7):1437-43.
2003: Luigi Rigacci; Massimo Federico; Maurizio Martelli; Pier Luigi Zinzani; Luigi Cavanna; Giampiero Bellesi; Francesco Merli; Renato Alterini; Maria Teresa Petrucci; Monica Tani; Anna Marina Liberati; Umberto Vitolo; Vincenzo Pavone; Antonio Cuneo; Teodoro Chisesib; Maura Brugiatelli
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
Leukemia & lymphoma 2003;44(11):1911-7.
2003: Roberto M Lemoli; Francesco Bertolini; Maria Teresa Petrucci; Chiara Gregorj; Maria R Ricciardi; Miriam Fogli; Antonio Curti; Cristina Rabascio; Simona Pandolfi; Sergio Ferrari; Robin Foá; Michele Baccarani; Agostino Tafuri; Cristina Rabascio; Robin Fo
Functional and kinetic characterization of granulocyte colony-stimulating factor-primed CD34- human stem cells.
British journal of haematology 2003;123(4):720-9.
2003: Maria Concetta Petti; Agostino Tafuri; Roberto Latagliata; Maria Antonietta Aloe-Spiriti; Enrico Montefusco; Marco Mancini; Giovanna Meloni; Maria Teresa Petrucci; Antonio Spadea; Roberta Redi; Giuliana Alimena; Franco Mandelli
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.
Annals of hematology 2003;82(8):476-80.
2003: Maria Teresa Petrucci; Maria Cristina Tirindelli; Marianna De Muro; Vincenza Martini; Anna Levi; Franco Mandelli
Extramedullary liver plasmacytoma a rare presentation.
Leukemia & lymphoma 2003;44(6):1075-6.
2003: Maria Teresa Petrucci; Giuseppe Avvisati; Giacinto La Verde; Paolo De Fabritiis; Michela Ribersani; Giovanna Palumbo; Lidia De Felice; Alessandra Rusignuolo; Francesca Simone; Giovanna Meloni; Franco Mandelli
Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma.
Acta haematologica 2003;109(4):184-8.
2002: Maria Teresa Petrucci; Maria R Ricciardi; Chiara Gregorj; Laura Ciapponi; Rocco Savino; Gennaro Ciliberto; Agostino Tafuri
Effects of IL-6 variants in multiple myeloma: growth inhibition and induction of apoptosis in primary cells.
Leukemia & lymphoma 2002;43(12):2369-75.
2002: Agostino Tafuri; Chiara Gregorj; Maria Teresa Petrucci; Maria R Ricciardi; Marco Mancini; Giuseppe Cimino; Cristina Mecucci; Alessandra Tedeschi; Giuseppe Fioritoni; Felicetto Ferrara; Francesco Di Raimondo; Eugenio Gallo; Vincenzo Liso; Francesco Fabbiano; Nicola Cascavilla; Giovanni Pizzolo; Andrea Camera; Fabrizio Pane; Francesco Lanza; Daniela Cilloni; Luciana Annino; Antonella Vitale; Maria Luce Vegna; Marco Vignetti; Robin Foà; Franco Mandelli
MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.
Blood 2002;100(3):974-81.
2002: Antonio Curti; Agostino Tafuri; Maria R Ricciardi; Pier Luigi Tazzari; Maria Teresa Petrucci; Miriam Fogli; Marina Ratta; Rosa Lapalombella; Elisa Ferri; Sante Tura; Michele Baccarani; Roberto M Lemoli
Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1).
Haematologica 2002;87(4):373-80.
2002: Alessandro Pulsoni; Nicoletta Villivà; Elena Cavalieri; Paolo Falcucci; Giacinto La Verde; Roberta Matera; Maria Teresa Petrucci; Maria Elena Tosti; Franco Mandelli
Continuous low dose of melphalan and prednisone in patients with multiple myeloma of very old age or severe associated disease.
Drugs & aging 2002;19(12):947-53.
2001: Maria Concetta Petti; M B Pinazzi; Daniela Diverio; Atelda Romano; Maria Teresa Petrucci; Silvia De Santis; Giovanna Meloni; Agostino Tafuri; Franco Mandelli; Francesco Lo Coco
Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676).
British journal of haematology 2001;115(1):63-5.
2001: Maria R Ricciardi; Maria Teresa Petrucci; Chiara Gregorj; Cristina Ariola; Roberto M Lemoli; Miriam Fogli; Francesca Romana Mauro; Raffaella Cerretti; Robin Foà; Franco Mandelli; Agostino Tafuri
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia.
British journal of haematology 2001;113(2):391-9.
2000: Maria Teresa Petrucci; Maria R Ricciardi; Chiara Gregorj; Cristina Ariola; F Mazzola; Miriam Fogli; Roberto M Lemoli; Agostino Tafuri
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells.
Leukemia & lymphoma 2000;40(1-2):179-90.
2000: Giovanna Meloni; Saveria Capria; Stefania Trasarti; Giancarlo Ferrazza; Alessandra Micozzi; Maria Teresa Petrucci; Francesca Simone; Silvia Trisolini; Franco Mandelli
High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study.
Bone marrow transplantation 2000;26(10):1045-9.
2000: Maria Teresa Petrucci; Agostino Tafuri; Franco Mandelli
[The role of biotherapy in multiple myeloma].
Recenti progressi in medicina 2000;91(10):488-93.
2000: Maria Teresa Petrucci; Giacinto La Verde; Michela Ribersani; Giuseppe Avvisati; Franco Mandelli
Intravenous melphalan and dexamethasone followed by lymphoblastoid alpha interferon in higher risk multiple myeloma patients.
Leukemia & lymphoma 2000;39(1-2):131-8.
2000: Alessandro Pulsoni; Paolo Falcucci; Gabriel Anghel; Michela Ribersani; Maria Teresa Petrucci; Edoardo Pescarmona; Luca Muscardin
Isolated granulocytic sarcoma of the skin in an elderly patient: good response to treatment with local radiotherapy and low-dose methotrexate.
Journal of the European Academy of Dermatology and Venereology : JEADV 2000;14(3):216-8.
2000: Antonio Palumbo; S Triolo; Luca Baldini; Vincenzo Callea; Antonio Capaldi; V De Stefano; Mariella Grasso; Marina Liberati; C Lotesoriere; R Marcenò; Filippo Marmont; Pellegrino Musto; Maria Teresa Petrucci; Mauro Spriano; Alessandro Pileri; Mario Boccadoro
Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.
Haematologica 2000;85(5):508-13.
2000: M Tribalto; Sergio Amadori; Laura Cudillo; Tommaso Caravita; Giovanni Del Poeta; G Meloni; Giuseppe Avvisati; Maria Teresa Petrucci; Alessandro Pulsoni; G Leone; Simona Sica; M Martelli; Antonio Tabilio; Giuseppe Fioritoni; Ignazio Majolino; Franco Mandelli
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.
Haematologica 2000;85(1):52-8.
1999: R Cauda; M B Lucia; G Marasca; Sergio Rutella; Maria Teresa Petrucci; Giacinto La Verde; R Gastaldi
Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy.
European journal of haematology 1999;63(2):134-5.
1999: Agostino Tafuri; Roberto M Lemoli; Maria Teresa Petrucci; Maria R Ricciardi; Miriam Fogli; Laura Bonsi; Cristina Ariola; Pierluigi Strippoli; Chiara Gregorj; Maria Concetta Petti; Sante Tura; Franco Mandelli; Gian Paolo Bagnara
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells.
Experimental hematology 1999;27(8):1255-63.
1999: Maria Teresa Petrucci; Maria R Ricciardi; Cristina Ariola; Chiara Gregorj; Michela Ribersani; Rocco Savino; Gennaro Ciliberto; Agostino Tafuri
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1.
Annals of hematology 1999;78(1):13-8.
1998: Alessandro Pulsoni; Giuseppe Avvisati; Maria Teresa Petrucci; Franco Mandelli; D Giannarelli; Vito Michele Lauta; M Tribalto; Alessandro Pileri
The Italian experience on interferon as maintenance treatment in multiple myeloma: ten years after.
Blood 1998;92(6):2184-6.
1997: Giacinto La Verde; Alessandro Pulsoni; Maria Teresa Petrucci; Franco Mandelli
[Therapy of multiple myeloma].
Recenti progressi in medicina 1997;88(4):186-93.
1997: Roberto M Lemoli; Agostino Tafuri; A Fortuna; Maria Teresa Petrucci; Maria R Ricciardi; Lucia Catani; Damiano Rondelli; Miriam Fogli; Giuliana Leopardi; Cristina Ariola; Sante Tura
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Blood 1997;89(4):1189-96.
1996: Maria Teresa Petrucci; Lidia De Felice; Maria R Ricciardi; Cristina Ariola; Maria Grazia Mascolo; SUSANNA FENU; Agostino Tafuri
Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis.
Cytokines and molecular therapy 1996;2(4):225-30.
1996: Roberto M Lemoli; A Fortuna; Agostino Tafuri; Miriam Fogli; Marilina Amabile; Alexis Grande; Maria R Ricciardi; Maria Teresa Petrucci; Laura Bonsi; Gian Paolo Bagnara; Giuseppe Visani; giovanni martinelli; Sergio Ferrari; Sante Tura
Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.
Blood 1996;87(9):3852-9.
1995: Agostino Tafuri; Lidia De Felice; Maria Teresa Petrucci; Maria Grazia Mascolo; Maria R Ricciardi; C Ciliberti; Maria Paola Martelli; Maria Concetta Petti
Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen.
Cytokines and molecular therapy 1995;1(4):301-7.
1995: G Avvisati; Maria Teresa Petrucci; Franco Mandelli
The role of biotherapies (interleukins, interferons and erythropoietin) in multiple myeloma.
Baillière's clinical haematology 1995;8(4):815-29.
1995: Agostino Tafuri; A Sommaggio; L Burba; M P Albergoni; Maria Teresa Petrucci; Maria Grazia Mascolo; Anna Maria Testi; Giuseppe Basso
Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia.
Leukemia research 1995;19(12):927-31.
1995: Piero Galieni; M Cavo; G Avvisati; Alessandro Pulsoni; R Falbo; M A Bonelli; D Russo; Maria Teresa Petrucci; Alessandro Bucalossi; Sante Tura
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(7):687-91.
1995: Agostino Tafuri; Lidia De Felice; A Goodacre; SUSANNA FENU; Maria Teresa Petrucci; T Valentini; Giuliana Alimena; Maria Concetta Petti; Giovanna Meloni; Franco Mandelli
Interleukin-3 priming in acute myeloid leukaemia patients.
British journal of haematology 1995;91(1):234-44.
1995: G Avvisati; Maria Teresa Petrucci
Is alpha-interferon treatment in multiple myeloma worthwhile?
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():106-13.
1993: Alessandro Pulsoni; P Bianco; Giacinto La Verde; Sergio Mecarocci; Maria Teresa Petrucci; Concetta Torromeo; Giuseppe Avvisati
Coexistent multiple myeloma and myelofibrosis.
Leukemia & lymphoma 1993;10(4-5):401-3.
1993: Agostino Tafuri; Lidia De Felice; Maria Grazia Mascolo; T Valentini; Maria Teresa Petrucci; Maria Concetta Petti
Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Stem cells (Dayton, Ohio) 1993;11 Suppl 2():88-92.
1990: Giuseppe Avvisati; Alessandro Pulsoni; Maria Teresa Petrucci; M Tribalto
[Therapy of multiple myeloma and its complications].
Recenti progressi in medicina 1990;81(10):642-50.
1990: Giuseppe Cimino; Giuseppe Avvisati; Sergio Amadori; M C Cava; Diana Giannarelli; G D Di Nucci; V Magliocca; Maria Teresa Petrucci; G Poti; Cecilia Sgadari
High serum IL-2 levels are predictive of prolonged survival in multiple myeloma.
British journal of haematology 1990;75(3):373-7.
1990: Giuseppe Avvisati; Maria Teresa Petrucci; Franco Mandelli
[Interferon: a new weapon in the therapeutic strategy of multiple myeloma].
Haematologica 1990;75 Suppl 4():68-71.
1990: Franco Mandelli; Giuseppe Avvisati; S Amadori; Mario Boccadoro; A Gernone; Vito Michele Lauta; Filippo Marmont; Maria Teresa Petrucci; M Tribalto; Maria Luce Vegna
Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
The New England journal of medicine 1990;322(20):1430-4.
1990: Giuseppe Avvisati; Maria Teresa Petrucci; Alessandro Pulsoni; M Tribalto; Vito Michele Lauta; A Gernone; Mario Boccadoro; Filippo Marmont; Alessandro Pileri; F Dammacco
Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma.
European journal of haematology. Supplementum 1990;52():9-11.
1989: Maria Teresa Petrucci; Giuseppe Avvisati; M Tribalto; P Giovangrossi; Franco Mandelli
Waldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patients.
Journal of internal medicine 1989;226(6):443-7.
1989: Maria Teresa Petrucci; Giuseppe Avvisati; M Tribalto; Maria Cantonetti; P Giovangrossi; Franco Mandelli
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatment.
European journal of haematology 1989;42(3):233-7.
1989: Alessandro Pileri; T Barbui; Mario Boccadoro; B Comotti; F Dammacco; Andrea Gallamini; Filippo Marmont; G Neretto; Maria Teresa Petrucci; Luigi Resegotti
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
Bone marrow transplantation 1989;4 Suppl 1():168-9.
1989: Giuseppe Cimino; Giuseppe Avvisati; Sergio Amadori; A O Di Gregorio; V Magliocca; Maria Teresa Petrucci; Cecilia Sgadari
High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
Nouvelle revue française d'hématologie 1989;31(5):329-32.
1988: M Tribalto; Giuseppe Avvisati; Maria Cantonetti; G Catalano; P Giovangrossi; M Masi; Maria Teresa Petrucci; A Venditti; G Papa
[Current aspects of treatment of multiple myeloma].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1988;3(3):193-202.
1988: Franco Mandelli; M Tribalto; Giuseppe Avvisati; Maria Cantonetti; Maria Teresa Petrucci; Mario Boccadoro; Alessandro Pileri; Filippo Marmont; Luigi Resegotti; Vito Michele Lauta
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
Cancer treatment reviews 1988;15 Suppl A():43-8.
1987: Giulio De Rossi; G De Sanctis; V Bottari; M Tribalto; M Lopez; Maria Teresa Petrucci; L Fontana
Surface markers and cytotoxic activities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma. Increased phytohemagglutinin-induced cellular cytotoxicity and inverted helper/suppressor cell ratio are features common to both diseases.
Cancer immunology, immunotherapy : CII 1987;25(2):133-6.
1986: Enrico Montefusco; Bruno Monarca; A Vitale; M Mancini; Maria Teresa Petrucci; M Tribalto
Monoclonal immunoglobulins associated with myeloproliferative disorders.
Haematologica 1986;71(3):233-6.